FDA Approves Once-Weekly Product for Hemophilia A FDA Approves Once-Weekly Product for Hemophilia A

The new product, efanesoctocog alfa (Altuviiio), is a long-acting factor VIII replacement that needs to be given only once weekly.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news